/Companies

Cerevasc

Auburndale, US · Founded 2020 · Delaware corporation · 37 employees on LinkedIn · 1 known investors

Find your way into Cerevasc

19 people in our graph can introduce you to the Cerevasc team.

Sign up to see every warm intro you have to Cerevasc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerevasc team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

Founders & leadership

Cerevasc was founded in 2020 by Carl Heilman and Daniel Levangie.

CHCarl Heilman
Carl HeilmanCo-founder
DLDaniel Levangie
Daniel LevangieCo-founder · President & CEODaniel Levangie is an experienced medical device executive who previously served as Chief Executive Officer of Dune Medical Devices and co-founded Constitution Medical Investors, a Boston-based product development firm acquired by Roche Diagnostics in 2013. He held multiple senior leadership roles at Cytyc Corporation before its acquisition by Hologic in 2007, and earlier worked in sales and management positions at Abbott Laboratories; he is a graduate of Northeastern University.
LTLeslie Teso-Lichtman
Leslie Teso-LichtmanSVP, Chief Financial Officer & Treasurer2020–2024
FC
Frederick CalloriNamed on SEC filing
PS
Patrick SullivanNamed on SEC filing
AL
Aaron LevangieNamed on SEC filing

Board

CGChris Garabedian
Chris GarabedianBoard Member2020–2025Investor at Perceptive Advisors

Investors · 1

Reported raises · per SEC filings

Form D private placements

$11.1M disclosed across 1 round · 2020

▶$11.1MraisedJun 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick CalloriDirector
  • Chris GarabedianDirector
  • Patrick SullivanDirector
  • Aaron LevangieExecutive Officer
  • Carl HeilmanDirector
  • Daniel LevangieExecutive Officer, Director
  • Leslie Teso-LichtmanExecutive Officer
Offering amount
$32.5M
Amount sold
$11.1M
First sale
May 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Cerevasc.

Frequently asked questions

What does Cerevasc do?
CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.
Who founded Cerevasc?
Cerevasc was founded by Carl Heilman, Daniel Levangie in 2020.
Who are Cerevasc's investors?
Cerevasc's investors include Bain Capital Life Sciences.
How much funding has Cerevasc raised?
Cerevasc has disclosed $11.1M raised across 1 round.
Where is Cerevasc headquartered?
Cerevasc is headquartered in Auburndale, US.